News

The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.

WuXi STA Opens New Large-scale Oligonucleotide and Peptide Manufacturing Facility

Thursday, July 07, 2022

WuXi STA a subsidiary of WuXi AppTec today announced the opening of a new largescale oligonucleotide and peptide manufacturing facility at its Changzhou campus The new facility underscores WuXi STAs ongoing commitment to enhance its capacity and capa...

Iveric Bio and DelSiTech Enter Exclusive Agreement for Development of Sustained Release Zimura®

Wednesday, July 06, 2022

IVERIC bio Inc and DelSiTech Ltd announced today an exclusive global license agreement providing Iveric Bio with the right to develop and commercialize new formulations of Zimura avacincaptad pegol using DelSiTechs silicabased sustained release techn...

Kyowa Kirin Expands License Agreement with Synaffix and Takes Exclusive Target Rights Based on Latest Positive ADC Data

Friday, July 01, 2022

Synaffix BV a biotechnology company focused on commercializing its clinicalstage platform technology for the development of antibodydrug conjugates ADCs with bestinclass therapeutic index today announces that Kyowa Kirin Co Ltd Kyowa Kirin TSE a glob...

BeiGene Announces Late-Breaking Data at ESMO GI Showing Overall Survival Benefit for Tislelizumab Plus Chemotherapy in First-Line Advanced or Metastatic Esophageal

Thursday, June 30, 2022

BeiGene a global sciencedriven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide today announced new data from RATIONALE a global Phase trial evaluating t...